货号:A372226
同义名:
美拉诺坦 II
/ Melanotan (MT)-II
Melanotan II是 α-黑素细胞刺激激素的类似物,是 MC3-R/MC4-R 黑色素皮质激素受体的激动剂,能够诱导黑色素生成,从而增加皮肤色素沉着。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
Concentration | Treated Time | Description | References | |
HEK 293T cells | 1 µM | 5, 10, 20, 40 minutes | To study MTII-mediated MC4R internalization and the effect of GRP78 knockdown on MC4R internalization. Results showed that GRP78 knockdown attenuated MTII-mediated receptor internalization. | Exp Mol Med. 2018 Sep 12;50(9):1-14 |
HDC neurons | 100 nM | MTII induced excitation of HDC neurons, leading to membrane depolarization and increased spontaneous firing rate. | Mol Metab. 2020 May;35:100956 | |
B16-F10 melanoma cells | 0.1 nM | 7 days | MTII dose-dependently suppressed the anchorage-independent growth of melanoma cells. | Int J Mol Sci. 2020 Jan 20;21(2):681 |
B16-F10 melanoma cells | 0.1 nM–1 μM | 16 hours | MTII dose-dependently inhibited the invasiveness of B16-F10 melanoma cells. | Int J Mol Sci. 2020 Jan 20;21(2):681 |
B16-F10 melanoma cells | 10 nM | 48 hours | MTII significantly attenuated the migration of B16-F10 melanoma cells but had no effect on cell proliferation. | Int J Mol Sci. 2020 Jan 20;21(2):681 |
Administration | Dosage | Frequency | Description | References | ||
Mice | Ob/ob mice and diet-induced obese (DIO) mice | Intracerebroventricular injection | 3 nmol | 5 days | To study the effect of MTII on body weight and food intake. Results showed that 4-PBA pretreatment overcame the antagonistic effect of AgRP and prolonged the effect of the MC4R agonist on food intake and body weight control. | Exp Mol Med. 2018 Sep 12;50(9):1-14 |
Mice | Hdc-Cre::hM4Di mice | Intracerebroventricular injection | 1 nmol | Single injection | Inhibition of HDC neurons strikingly enhanced the anorexigenic effects of MTII, suggesting that MC4R activation of histaminergic neurons may restrain the anorexigenic effects of melanocortin system activation. | Mol Metab. 2020 May;35:100956 |
C57BL/6 mice | B16-F10 melanoma model | Topical administration | 0.1 mL of 1 μg/mL MTII in PBS | Once daily for 10 days | Topical MTII therapy significantly suppressed the progression of melanoma in mice through proliferation inhibition, apoptosis induction, and neovascularization blockade. | Int J Mol Sci. 2020 Jan 20;21(2):681 |
Prairie voles | Female and male prairie voles | Intraperitoneal injection | 10 mg/kg | Single injection | MTII facilitated partner preference formation in both female and male prairie voles, and this effect persisted for 7 days post-injection. | Neuropsychopharmacology. 2015 Jul;40(8):1856-65 |
Sprague-Dawley rats | Myocardial infarction model | Intracerebroventricular injection | 10 ng/h | 28 consecutive days | Activation of CNS MC4R significantly improved cardiac function post-MI and attenuated the progression of heart failure. | JACC Basic Transl Sci. 2021 Jan 25;6(1):55-70 |
Mice | Obesity model | Intraperitoneal injection | 3 mg/kg | Single dose | To evaluate the effect of MT-II on food intake and body weight, results showed that MT-II significantly reduced food intake. | Mol Metab. 2023 Feb;68:101665 |
Mice | ArcPomc-/- obese mouse model | Intraperitoneal injection | 100μg/animal | Single dose with measurements within 4 hours | To evaluate MTII's effect on circulating adiponectin levels; Results showed MTII treatment significantly reduced adiponectin levels in both ArcPomc-/- and wild-type mice | Mol Metab. 2020 May;35:100957 |
Mice | ArcPOMC-deficient mice | Intracerebroventricular injection | 0.5 mg | Three times daily, lasting 30 minutes | MTII treatment reversed the improved glucose tolerance and glycosuria phenotype in mutant mice | Diabetes. 2016 Mar;65(3):660-72 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
0.98mL 0.20mL 0.10mL |
4.88mL 0.98mL 0.49mL |
9.76mL 1.95mL 0.98mL |
CAS号 | 121062-08-6 |
分子式 | C50H69N15O9 |
分子量 | 1024.18 |
SMILES Code | O=C([C@@H](NC([C@@](NC([C@@H](NC([C@@H](NC([C@@H](NC(C)=O)CCCC)=O)CC(NCCCC[C@](C(N)=O)([H])NC1=O)=O)=O)CC2=CN=CN2)=O)([H])CC3=CC=CC=C3)=O)CCCNC(N)=N)N[C@H]1CC4=CNC5=CC=CC=C45 |
MDL No. | MFCD01318793 |
别名 | 美拉诺坦 II ;Melanotan (MT)-II |
运输 | 蓝冰 |
InChI Key | JDKLPDJLXHXHNV-MFVUMRCOSA-N |
Pubchem ID | 92432 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, store in freezer, under -20°C |
溶解方案 |
H2O: 6.5 mg/mL(6.35 mM),配合低频超声助溶 |